SEQIRUS
Live / Registered — Registered — partial Sections 8 & 15 accepted and acknowledged (as of 15 Mar 2024)
What this means for you
Registered since 21 Mar 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86726994
- Registration number
- 5163878
- Mark type
- Stylized text
- Filed
- 17 Aug 2015
- Published for opposition
- 18 Oct 2016
- Registered
- 21 Mar 2017
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 001 — Chemicals: [ Chemical and biological reagents for scientific and non-medical purposes; cell cultures and media for laboratory, scientific and research use; test kits for scientific and non-medical laboratory use for anti-body screening, blood grouping or detection of specific blood cells, antigens and immunoglobulin subtypes; chemical preparations for scientific and industrial purposes; diagnostic and testing agents for scientific and non-medical purposes; Chemical and biological reagents for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells ]
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for [the treatment and ] prevention of [ blood disorders, bleeding disorders, and ] diseases caused by [ bacteria and ] viruses; vaccines; [ blood products, namely, immunoglobulins for medical or clinical use; medicated serums for the treatment of influenza; anti-virals; ] influenza vaccines; adjuvants and antigens for medical purposes; [ blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood disorders and bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, Rheysys Factor D Antigen reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies and Immunoglobulin subtypes; ] pharmaceutical preparations, namely, therapeutic monoclonal and polyclonal antibodies and antibodies for use in the treatment of infectious diseases [ ; pharmaceutical preparations, namely, reagents for medical and clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes ]
- Class 044 — Medical, beauty and agricultural services: Medical services; medical information services; health care services; health care information services, namely, internet-based health care information services; [ providing medical information concerning blood products; ] providing medical information concerning vaccines [, anti-venoms and immunohematology products, namely, diagnostic reagents; patient support services, namely, providing an Internet-based database of patient medical information, where patients can enquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community ]
Owner
- Seqirus UK Limited, Berkshire, GB
- Seqirus UK Limited, London, England, GB
- Seqirus UK Limited, London, England, GB
Prosecution history
- 21 Mar 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 15 Mar 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 Mar 2024 — REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 Mar 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 21 Sept 2023 — TEAS SECTION 8 & 15 RECEIVED
- 21 Mar 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Nov 2019 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Nov 2019 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 18 Dec 2018 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 18 Dec 2018 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Mar 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Feb 2017 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 05 Jan 2017 — NOTICE OF ALLOWANCE CANCELLED
- 21 Jan 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 05 Jan 2017 — TEAS DELETE 1(B) BASIS RECEIVED